Sarepta Pipeline Presentation


In this webinar, Sarepta Therapeutics presents an update on their Duchenne muscular dystrophy pipeline. Diane Berry, PhD, Senior Vice President, Global Health Policy, Government and Patient Affairs and Louise Rodino-Klapac, PhD, Senior Vice President, Gene Therapy speak on the webinar. The webinar provides an overview of Sarepta’s scientific research platforms, active clinical trial programs and information about educational resources.

Recorded: Jun 11, 2020 04:00 PM in Eastern Time (US and Canada)

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.